Bladder

TAR-200 implant achieves complete remission in 82% of bladder cancer patients

Slow-release TAR-200 device helps over 80% of high-risk bladder cancer patients avoid surgery and remain cancer-free for years.

Urine-powered nanorobots shrink bladder tumors by 90%, study finds Joshua Shavit

Groundbreaking genetic test can predict bladder cancer years before diagnosis Joseph Shavit